Symbol
| SPR
| contributors: mct - updated : 12-11-2019
|
HGNC name
| sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
HGNC id
| 11257
|
corresponding disease(s)
|
SPRD
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
is significantly correlated to unfavorable Neuroblastoma (NB) characteristics like high age at diagnosis  | |
Variant & Polymorphism
|
| |
Candidate gene
| for PARK3 |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
miscelleaneous | pain | |  |
tranilast can act as a potent SPR inhibitor and therefore is a valid candidate for drug repurposing in the treatment of chronic pain | immunology | autoimmune | articular |  |
SPR inhibition reduces pain associated with joint inflammation, showing potential utility as an analgesic strategy for inflammatory joint pain |
| | |